Significance of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies in patients with lupus nephritis

References

• Mok CC, Yap DY, Navarra SV, et al. Overview of lupus nephritis management guidelines and perspective from Asia. Int J Rheum Dis. 2013;16(6):625–636.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 2016;68(6):1432–1441.
   PubMed Web of Science ®Google Scholar
• Hermansen ML, Lindhardsen J, Torp-Pedersen C, et al. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study. Rheumatology (Oxford). 2017;56(5):709–715.
   PubMed Web of Science ®Google Scholar
• To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 2005;52(12):4003–4010.
   PubMedGoogle Scholar
• Kalaaji M, Fenton KA, Mortensen ES, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int. 2007;71(7):664–672.
   PubMed Web of Science ®Google Scholar
• Krishnan MR, Wang C, Marion TN. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int. 2012;82(2):184–192.
   PubMed Web of Science ®Google Scholar
• Cortes-Hernandez J, Ordi-Ros J, Labrador M, et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med. 2004;116(3):165–173.
   PubMed Web of Science ®Google Scholar
• Bigler C, Lopez-Trascasa M, Potlukova E, et al. Antinucleosome antibodies as a marker of active proliferative lupus nephritis. Am J Kidney Dis. 2008;51(4):624–629.
   PubMed Web of Science ®Google Scholar
• Linnik MD, Hu JZ, Heilbrunn KR, et al. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(4):1129–1137.
   PubMedGoogle Scholar
• Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum. 2006;54(2):421–432.
   PubMedGoogle Scholar
• Choi HW, Kwon YJ, Park JH, et al. Evaluation of a fully automated antinuclear antibody indirect immunofluorescence assay in routine use. Front Immunol. 2020;11:607541.
   PubMed Web of Science ®Google Scholar
• Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–530.
   PubMed Web of Science ®Google Scholar
• Austin HA, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983;75(3):382–391.
   PubMed Web of Science ®Google Scholar
• Petri MA, van Vollenhoven RF, Buyon J, et al. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Arthritis Rheum. 2013;65(8):2143–2153.
   PubMed Web of Science ®Google Scholar
• Lindblom J, Mohan C, Parodis I. Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights. Curr Opin Rheumatol. 2022;34(2):139–149.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Villalta D, Giavarina D, et al. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev. 2012;12(2):97–106.
   PubMed Web of Science ®Google Scholar
• Gioud M, Kaci MA, Monier JC. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthritis Rheum. 1982;25(4):407–413.
   PubMedGoogle Scholar
• Helve T, Gripenberg M, Kurki P, et al. Enzyme-linked immunosorbent assays for antibodies to poly(a), poly dAT and histones: possibly useful tools for the evaluation of prognosis and disease activity in systemic lupus erythematosus. Rheumatol Int. 1984;4(2):75–78.
   PubMed Web of Science ®Google Scholar
• Shang X, Ren L, Sun G, et al. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Immun Inflamm Dis. 2021;9(2):407–418.
   PubMed Web of Science ®Google Scholar
• Bonanni A, Vaglio A, Bruschi M, et al. Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference. Autoimmun Rev. 2015;14(8):692–702.
   PubMed Web of Science ®Google Scholar
• Yang J, Xu Z, Sui M, et al. Co-positivity for anti-dsDNA, -nucleosome and -histone antibodies in lupus nephritis is indicative of high serum levels and severe nephropathy. PLOS One. 2015;10(10):e0140441.
   PubMed Web of Science ®Google Scholar
• Sui M, Lin Q, Xu Z, et al. Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis. J Clin Immunol. 2013;33(2):378–387.
   PubMed Web of Science ®Google Scholar
• Yang XW, Tan Y, Yu F, et al. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Nephrol Dial Transplant. 2012;27(9):3552–3559.
   PubMed Web of Science ®Google Scholar
• Reichlin M, Mattioli M. Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med. 1972;286(17):908–911.
   PubMed Web of Science ®Google Scholar
• Farber SJ, Bole GG. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients. Arch Intern Med. 1976;136(4):425–431.
   PubMedGoogle Scholar
• ter Borg EJ, Groen H, Horst G, et al. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1990;20(3):164–173.
   PubMed Web of Science ®Google Scholar
• Meyer O, Bourgeois P, Aeschlimann A, et al. Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens. Ann Rheum Dis. 1989;48(7):594–599.
   PubMed Web of Science ®Google Scholar
• Alba P, Bento L, Cuadrado MJ, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis. 2003;62(6):556–560.
   PubMed Web of Science ®Google Scholar
• Bastian HM, Roseman JM, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002;11(3):152–160.
   PubMed Web of Science ®Google Scholar
• Heidenreich U, Mayer G, Herold M, et al. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis. Lupus. 2009;18(14):1276–1280.
   PubMed Web of Science ®Google Scholar
• van Bavel CC, Dieker JW, Tamboer WP, et al. Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes. Mol Immunol. 2010;48(1–3):248–256.
   PubMed Web of Science ®Google Scholar
• Khan MA, Alam K, Hassan SM, et al. Nitration of H2B histone elicits an immune response in experimental animals. Autoimmunity. 2017;50(4):232–240.
   PubMed Web of Science ®Google Scholar
• Jaekell HP, Trabandt A, Grobe N, et al. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus. 2006;15(6):335–345.
   PubMed Web of Science ®Google Scholar
• Kiss E, Lakos G, Szegedi G, et al. Anti-nuscleosome antibody, a reliable indicator for lupus nephritis. Autoimmunity. 2009;42(5):393–398.
   PubMed Web of Science ®Google Scholar